Obesity is linked to a whole host of health problems, but as its heavy cost on our society becomes apparent, we could see more emphasis placed on healthy living. To that end, a new study links a reduction in body mass to an improvement in psoriasis -- what looks like dry, red itchy skin but is in fact autoimmune condition.
In this video, health-care analyst David Williamson discusses the findings of this study along with a new potential drug aiming to treat psoriasis suffers with arthritis, a common condition that could add another blockbuster product to this biotech stocks portfolio.
David Williamson has no position in any stocks mentioned. The Motley Fool recommends Celgene. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.